Questionnaires
Description
xxxxxx
How to know if you are considered as a Commercial User or an Academic User?
If you are unsure of whether you are a commercial user or an academic user , please refer to our Terms and Conditions.
Conditions of use for Commercial Users
Commercial use requires charge, a User Agreement is required for each study.
xxxx.
To enquire about a commercial use, please contact us.
Conditions of use for Academic Users
Academic use requires no charge, but an Academic User Agreement is required for each study.
In order to be able to use the QLQ-C30 and modules you need to obtain the permission via our download process below. By completing the process you are authorised to use the questionnaire in the study you mentioned. For each new study, you will have to enter a new download request.
List of questionnaires
| Code | Name | ||
|---|---|---|---|
| QLQ-C30 | Quality of Life of Cancer Patients | Core | validated |
| AYA | Adolescents and Young Adults | Core | I / II - in development |
| QLQ-ANL27 | Anal Cancer | Module | IV - in development |
| QLQ-BM22 | Bone Metastases | Module | validated |
| QLQ-BN20 | Brain | Module | validated |
| QLQ-BR23 | Breast | Module | validated |
| QLQ-BR45 | Breast Cancer (update of QLQ-BR23) | Module | IV - pending |
| QLQ-BRECON23 | Breast Reconstruction | Module | validated |
| QLQ-CAX24 | Cancer Cachexia | Module | IV - in development |
| QLQ-FA12 | Cancer related Fatigue | Module | validated |
| QLQ-CX24 | Cervical | Module | validated |
| QLQ-CIPN20 | Chemotherapy-Induced Peripheral Neuropathy | Module | III - completed |
| QLQ-BIL21 | Cholangiocarcinoma and Gallbladder Cancer | Module | validated |
| QLQ-CLL17 | Chronic Lymphocytic Leukaemia | Module | IV - in development |
| QLQ-CML24 | Chronic Myeloid Leukaemia | Module | IV - in development |
| QLQ-CR29 | Colorectal | Module | validated |
| QLQ-LMC21 | Colorectal Liver Metastases | Module | validated |
| QLQ-COMU26 | Communication | Standalone | IV - in development |
| QLQ-ELD14 | Elderly Cancer Patients | Module | validated |
| QLQ-EN24 | Endometrial | Module | validated |
| QLQ-STO22 | Gastric | Module | validated |
| QLQ-H&N35 | Head & Neck | Module | validated |
| QLQ-H&N43 | Head & Neck Cancer (update of QLQ-H&N35) | Module | IV - completed |
| QLQ-HCC18 | Hepatocellular Carcinoma | Module | validated |
| HCPS | Hereditary Cancer Predisposition Syndrome | Module | I / II - in development |
| QLQ-HDC29 | High-Dose Chemotherapy | Module | III - completed |
| QLQ-NHL-HG29 | High Grade Non-Hodgkin’s Lymphoma | Module | IV - in development |
| QLQ-HL27 | Hodgkin’s Lymphoma | Module | IV - in development |
| IADL | IADL in Brain Tumor Patients | Module | III - in development |
| QLQ-INFO25 | Information | Module | validated |
| QLQ-NHL-LG20 | Low Grade Non-Hodgkin’s Lymphoma | Module | IV - in development |
| QLQ-LC13 | Lung | Module | validated |
| QLQ-LC29 | Lung Cancer (update of QLQ-LC13) | Module | IV - in development |
| QLQ-MEL38 | Melanoma | Module | III - completed |
| QLQ-MY20 | Multiple Myeloma | Module | validated |
| QLQ-BLM30 | Muscle Invasive Bladder Cancer | Module | III - completed |
| QLQ-NPC42 | Nasopharyngeal Carcinoma | Module | III - in development |
| QLQ-GINET21 | Neuroendocrine Carcinoid | Module | validated |
| QLQ-NMIBC24 | Non-Muscle-Invasive Bladder Cancer | Module | III - completed |
| QLQ-OES18 | Oesophageal | Module | validated |
| QLQ-OG25 | Oesophago-Gastric | Module | validated |
| QLQ-OPT30 | Ophthalmic Cancer | Module | III - completed |
| QLQ-OH15 | Oral Health | Module | validated |
| QLQ-OV28 | Ovarian | Module | validated |
| QLQ-PAN26 | Pancreatic Cancer | Module | III - completed |
| pNET | Pancreatic Neuroendocrine Tumour | Module | I / II - in development |
| QLQ-PR25 | Prostate | Module | validated |
| QLQ-C15-PAL | Quality of Life in palliative cancer care patients | Core | validated |
| QLQ-PRT23 | Radiation Proctitis | Module | IV - completed |
| QLQ-PATSAT-C33 | Satisfaction with Cancer Care – Core questionnaire | Standalone | IV - pending |
| QLQ-OUT-PATSAT7 | Satisfaction with Outpatient Cancer Care | Standalone | IV - pending |
| QLQ-SHQ22 | Sexual Health | Standalone | IV - in development |
| SCC | Spinal Cord Compression | Module | I / II - in development |
| QLQ-SWB32 | Spiritual Wellbeing | Standalone | validated |
| SURV111 | Survivorship | Core | III - in development |
| SBQ | Symptom-based questionnaire | Standalone | III - in development |
| QLQ-TC26 | Testicular Cancer | Module | IV - completed |
| QLQ-THY34 | Thyroid Cancer | Module | IV - in development |
| QLQ-VU34 | Vulva Cancer | Module | IV - pending |